​

Immunovant (IMVT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Immunovant Revenue Highlights

0

Latest Revenue (Q)

$7.09M

Immunovant Revenue by Period

Immunovant Revenue by Year

DateRevenueChange
2026-03-31-100.00%
2025-03-31-100.00%
2024-03-31-100.00%
2023-03-31-100.00%
2022-03-31-100.00%
2021-03-31-100.00%
2020-03-31-100.00%
2019-03-31-100.00%
2018-03-31--

Immunovant generated - in revenue during NA 2026, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Immunovant Revenue by Quarter

DateRevenueChange
2026-06-30$7.09M100.00%
2026-03-31-100.00%
2025-12-31-100.00%
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30--

Immunovant generated $7.09M in revenue during Q1 2027, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Immunovant Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ACADACADIA Pharmaceuticals$957.80M$307.96M
RAREUltragenyx Pharmaceutical$673.00M$214.00M
KYMRKymera Therapeutics$39.20M$65.00M
NAMSNewAmsterdam Pharma$22.50M$3.70M
CRNXCrinetics Pharmaceuticals$5.42M$25.12M
AKROAkero Therapeutics--
VKTXViking Therapeutics--
IMVTImmunovant-$7.09M
DYNDyne Therapeutics--
PRAXPraxis Precision Medicines--

IMVT Revenue FAQ

What is Immunovant’s yearly revenue?

Immunovant's yearly revenue for 2026 was $0, representing an increase of 100.00% compared to 2025. The company's yearly revenue for 2025 was $0, representing an increase of 100.00% compared to 2024. IMVT's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023.

What is Immunovant’s quarterly revenue?

Immunovant's quarterly revenue for Q1 2027 was $7.1M, a 100.00% increase from the previous quarter (Q4 2026), and a 0% increase year-over-year (Q1 2026). The company's quarterly revenue for Q4 2026 was $0, a 100.00% increase from the previous quarter (Q3 2026), and a 0% increase year-over-year (Q4 2025). IMVT's quarterly revenue for Q3 2026 was $0, a 100.00% increase from the previous quarter (Q2 2026), and a 0% increase year-over-year (Q3 2025).

What is Immunovant’s revenue growth rate?

Immunovant's revenue growth rate for the last 3 years (2024-2026) was 0%, and for the last 5 years (2022-2026) was 0%.